Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07742293

Effects of Two Different Kinesiotaping Techniques in Carpal Tunnel Syndrome

This study aims to evaluate the clinical, functional, and ultrasonographic effects of two different kinesiotaping techniques added to a standard exercise and night splint program in the treatment of Carpal Tunnel Syndrome (CTS). Participants will be randomly assigned to one of three groups: the I-Strip kinesiotaping technique group, the Button Hole kinesiotaping technique group, or a control group receiving only standard therapy. The study will assess treatment outcomes over a 12-week period using high-resolution ultrasound (specifically median nerve cross-sectional area and flattening ratio) and clinical parameters to determine the most effective conservative management approach.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Carpal Tunnel Syndrome (CTS) is the most common entrapment neuropathy, typically managed conservatively with tendon and nerve gliding exercises alongside night splints. Recently, Kinesiotaping (KT) has gained popularity for its space-correction mechanism, which aims to increase microcirculation and reduce mechanical pressure on the median nerve. While immediate effects of KT have been studied, there is a lack of literature comparing the long-term structural and clinical effects of specific taping methods.

This prospective, randomized controlled, evaluator-blinded trial is designed to compare the 12-week efficacy of the original "I-Strip" and "Button Hole" kinesiotaping techniques when combined with standard exercise and splint therapy, against a standard therapy-only control group.

The primary objective is to investigate morphological changes in the median nerve using high-resolution neurosonography, specifically tracking the Cross-Sectional Area (CSA) and Flattening Ratio (FR) at the carpal tunnel inlet. Secondary objectives include evaluating improvements in pain and upper extremity functionality. By objectively monitoring structural recovery through dynamic ultrasound imaging, this study aims to provide evidence-based recommendations on the long-term anatomical and clinical benefits of different kinesiotaping applications in CTS management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Being aged between 18 and 65 years.

  • Willingness and ability to sign the informed consent form.
  • Having symptoms of carpal tunnel syndrome (hand numbness, tingling, pain) for at least 3 months.
  • Clinical diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by physical examination (positive Phalen/Tinel tests) and a prior nerve conduction study (EMG).

Exclusion criteria

  • Previous wrist or hand surgery.
  • Severe carpal tunnel syndrome on EMG (evidence of thenar atrophy or severe motor loss).
  • History of trauma, fracture in the wrist area, or anatomical anomalies affecting ultrasonography.
  • Cervical radiculopathy, polyneuropathy, diabetic neuropathy, or other concomitant upper extremity entrapment neuropathies.
  • Local corticosteroid injection to the carpal tunnel within the last 6 months.
  • Pregnancy.
  • Systemic corticosteroid use or inflammatory rheumatic diseases.
  • Cognitive impairment or psychiatric illness preventing comprehension of questionnaire instructions.
  • Lack of a prior EMG report upon admission to the outpatient clinic.

Treatment and study plan

I-Strip Kinesiotaping and Standard Therapy

Other

Application of the original I-Strip kinesiotaping technique combined with a standard program of tendon/nerve gliding exercises and a night splint for 12 weeks.

Button Hole Kinesiotaping and Standard Therapy

Other

Application of the Button Hole kinesiotaping technique combined with a standard program of tendon/nerve gliding exercises and a night splint for 12 weeks.

Standard Exercise and Splint Therapy

Other

Twelve weeks of tendon/nerve gliding exercises and night splinting.

Primary outcomes

  1. Median Nerve Flattening Ratio (FR)

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

    Measurements will be taken at the pisiform bone level using resolution ultrasound.

  2. Median Nerve Cross-Sectional Area (CSA)

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

    Using high-resolution ultrasound, measurements will be taken in millimeters square (mm2) at the pisiform bone level.

Secondary outcomes

  1. Visual Analog Scale (VAS) for Pain (Rest and activity pain intensity, 0-10 cm)

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

    Measured on a 0 to 100 mm scale (where 0 indicates no pain and 100 indicates the worst imaginable pain); higher scores indicate a worse outcome.

  2. Visual Analog Scale (VAS) for Numbness/Paresthesia (Median nerve trajectory, 0-10 cm)

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

  3. Boston Carpal Tunnel Questionnaire (BCTQ) for Symptom Severity and Functional Status

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

  4. Douleur Neuropathique 4 (DN4) Questionnaire Score

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

    Scale from 0 to 10; higher scores indicate a greater likelihood of neuropathic pain.

  5. Jamar Dynamometer Grip Strength in Kilograms (kg)

    Time frame: At baseline (T0), 3rd week (T1), and 12th week (T2)

    The average of three consecutive measurements taken in kilograms (kg) using a Jamar dynamometer; higher values indicate better grip strength.

Study contacts

Contact information is provided by the study sponsor or research team.

Furkan Erdinc, MD

CONTACT

[email protected]

+905413216609

Sponsors and collaborators

Lead sponsor

Kayseri City Hospital

Other Gov

Registry information

Official study title

Effect of Two Different Kinesiotaping Techniques Added to Exercise on Clinical, Functional, and Ultrasonographic Outcomes in Carpal Tunnel Syndrome: A Randomized Controlled, Evaluator-Blinded Study

Acronym: CTS-TAPE

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 3, 2026
Registry last updated
Aug 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.